Press release
Gemigliptin Market Revenue Report with Forecast to 2031
The global Gemigliptin Market is estimated to reach over USD 2.65 billion by 2031, exhibiting a CAGR of 5.5% during the forecast period.
Request For Free Sample Pages:
https://www.insightaceanalytic.com/request-sample/2031
Gemigliptin is an oral medication used in the management of type 2 diabetes, classified under the dipeptidyl peptidase-4 (DPP-4) inhibitors. It is primarily employed to treat type 2 diabetes, a chronic metabolic disorder characterized by insulin resistance and elevated blood glucose levels. Gemigliptin exerts its therapeutic effects by inhibiting the DPP-4 enzyme, which is responsible for the breakdown of incretin hormones that play a crucial role in regulating blood glucose.
By blocking the action of DPP-4, Gemigliptin enhances the levels of incretin hormones, thereby improving insulin secretion and reducing hepatic glucose production. The growing prevalence of diabetes globally, coupled with the increasing acceptance of effective oral antidiabetic medications, has contributed to the steady expansion of the global Gemigliptin market.
List of Prominent Players in the Gemigliptin Market:
• LG Chem
• Hanmi Pharmaceutical Co., Ltd.
• Boryung Pharmaceutical Co., Ltd.
• Novartis AG
• EirGenix, Inc.
• Biocon Limited
• G.L. Pharma GmbH
• Daewoong Pharmaceutical Co., Ltd.
• Sandoz International GmbH
• Boryung Pharmaceutical Co., Ltd.
• VHB Life Sciences Limited
• HanAll Biopharma
• Taiba Healthcare
• Huons Co., Ltd.
• Dong-A ST Co., Ltd
Market Dynamics:
Drivers-
The global prevalence of diabetes is increasing at a concerning rate, affecting millions of individuals worldwide. As diabetes becomes a significant public health issue, the demand for effective and safe antidiabetic medications, such as Gemigliptin, is rising to manage the condition and enhance patient outcomes. Furthermore, oral antidiabetic medications are gradually replacing insulin injections due to their ease of administration and convenience
Curious about this latest version of the report? @
https://www.insightaceanalytic.com/enquiry-before-buying/2031
Challenges:
Gemigliptin faces substantial competition from other established antidiabetic drugs, such as metformin, sulfonylureas, and SGLT-2 inhibitors. These well-established treatments, which have demonstrated long-term efficacy, may impede the market penetration of newer therapies like Gemigliptin. Additionally, the expiration of patents for Gemigliptin and other DPP-4 inhibitors could lead to the emergence of generic alternatives, potentially creating pricing pressures and limiting revenue prospects for the branded version of Gemigliptin.
Regional Trends:
The North American market for Gemigliptin is expected to maintain a dominant share, with strong growth projected over the coming years. The rising prevalence of type 2 diabetes in the region, driven by factors such as sedentary lifestyles, poor dietary habits, and obesity, is a key factor supporting the demand for Gemigliptin. Additionally, North America's advanced healthcare infrastructure ensures broad availability and effective treatment of diabetes, enhancing the accessibility of medications like Gemigliptin. In the Asia-Pacific region, the rapid rise in type 2 diabetes cases, fueled by urbanization, changing lifestyles, and dietary shifts, has created a substantial market opportunity. However, the growing generics market in Asia could introduce competitive challenges for branded therapies like Gemigliptin, especially with the potential availability of generic DPP-4 inhibitors.
Recent Developments:
• In March 2023, Sanofi introduced a new fixed-dose combination medication, including gemigliptin and saxagliptin (Jentadueto XR), in the United States. This medicine is indicated for treating individuals with type 2 diabetes mellitus who are not effectively controlled with diet and exercise alone or with other diabetes drugs.
Get Specific Chapter/Information From The Report:
https://www.insightaceanalytic.com/customisation/2031
Segmentation of Gemigliptin Market-
By Type of Drug-
• Gemigliptin Monotherapy
• Gemigliptin Combination Therapy)
By Dosage Form-
• Gemigliptin Tablets
• Gemigliptin Injectable
By Distribution Channel-
• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies
By End-User-
• Hospitals
• Clinics and Outpatient Facilities
• Homecare Settings
By Application-
• Type 2 diabetes
• Prediabetes
By Patient Demographics-
• Adult Population
• Geriatric Population
By Region-
North America-
• The US
• Canada
• Mexico
Europe-
• Germany
• The UK
• France
• Italy
• Spain
• Rest of Europe
Asia-Pacific-
• China
• Japan
• India
• South Korea
• South East Asia
• Rest of Asia Pacific
Latin America-
• Brazil
• Argentina
• Rest of Latin America
Middle East & Africa-
• GCC Countries
• South Africa
• Rest of the Middle East and Africa
Get more information :@
https://www.insightaceanalytic.com/report/gemigliptin-market/2031
Contact us:
info@insightaceanalytic.com
InsightAce Analytic Pvt. Ltd.
Visit: www.insightaceanalytic.com
Tel : +1 551 226 6109
Asia: +91 79 72967118
Follow Us on LinkedIn @ bit.ly/2tBXsgS
Follow Us On Facebook @ bit.ly/2H9jnDZ
Twitter: https://twitter.com/Insightace
About Us:
InsightAce Analytic is a market research and consulting firm that enables clients to make strategic decisions. Our qualitative and quantitative market intelligence solutions inform the need for market and competitive intelligence to expand businesses. We help clients gain a competitive advantage by identifying untapped markets, exploring new and competing technologies, segmenting potential markets, and repositioning products. Our expertise is in providing syndicated and custom market intelligence reports with an in-depth analysis with key market insights in a timely and cost-effective manner.https://www.insightaceanalytic.com/images_data/148861653.JPG
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Gemigliptin Market Revenue Report with Forecast to 2031 here
News-ID: 4011088 • Views: …
More Releases from Insightace Analytic Pvt Ltd.
Bio Acrylic Acid Market Exclusive Trends Analysis with Forecast to 2031
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Bio Acrylic Acid Market Size, Share & Trends Analysis Report by Derivative Products (Methyl Acrylate, Butyl Acrylate, Ethyl Acrylate, 2-Ethylhexyl Acrylate, Glacial Acrylic Acid, And Super Absorbent Polymers) And Applications (Paints and Coatings, Adhesives And Sealants, Surfactants, Sanitary Products, Textiles)- Market Outlook And Industry Analysis 2031"
The global bio acrylic acid market is estimated to reach…
GMP Cell Therapy Consumables Market Exclusive Report with Detailed Study Analysi …
InsightAce Analytic Pvt. Ltd. announces the release of the market assessment report on "Global GMP Cell Therapy Consumables Market Size, Share & Trends Analysis Report By Product (Kits, Reagents/Molecular Biology Reagents, Growth Factors/Cytokines and Interleukins, and Others), Cell Therapy (NK Cell Therapy, Stem Cell Therapy, T-Cell Therapy, and Others), Process (Cell Collection and Characterization/Sorting and Separation, Cell Culture and Expansion/Preparation, Cryopreservation, Cell Processing and Formulation, Cell Isolation and Activation, Cell…
Gastrointestinal Endoscopy Market Exclusive Report on the Latest Revenue and Fut …
InsightAce Analytic Pvt. Ltd. announced the publication of a market research report titled " Global Gastrointestinal Endoscopy Market By Type(Gastrointestinal Endotherapy, (ERCP Devices, Gastrointestinal Stents (Esophageal Stents, Biliary Stents, Pancreatic Stents), Balloon Dilators, Ultrasound Endoscopes, Biopsy Devices (Biopsy Forceps, Polypectomy Snares, Other Biopsy Devices), Hemostasis Devices, Retrieval Devices, Others), Gastrointestinal Endoscopes and Endoscopic Systems (Gastrointestinal Videoscopes (Gastroscopes, Colonoscopes, Duodenoscopes, Sigmoidoscopes, Enteroscopes, Anoscopes), Visualization Systems, Capsule Endoscopes), End-User (Hospitals, Ambulatory Surgery…
High-End Synthetic Suede Market Report Latest Trends and Future Opportunities An …
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global High-End Synthetic Suede Market Size, Share & Trends Analysis Report By Product (Woven And Non-Woven) And Application (Automotive, Fashion, Furniture And Other Applications (Including Residential And Commercial))- Market Outlook And Industry Analysis 2031"
The High-End Synthetic Suede Market is estimated to reach over USD 2.06 billion by exhibiting a CAGR of 5.75% during the…
More Releases for Gemigliptin
Gemigliptin Market Regional Outlook, Leading Companies, Product, End Users for t …
The global Gemigliptin market is carefully researched in the report while largely concentrating on top players and their business tactics, geographical expansion, market segments, competitive landscape, manufacturing, and pricing and cost structures. Each section of the research study is specially prepared to explore key aspects of the global Gemigliptin market. For instance, the market dynamics section digs deep into the drivers, restraints, trends, and opportunities of the global Gemigliptin Market.…
Gemigliptin Market Regional Growth Drivers, Opportunities and Trends 2021-2027| …
The Gemigliptin market report gives an itemized examination of worldwide market size, territorial and nation level market size, division market development, piece of the pie, cutthroat Landscape, deals investigation, effect of homegrown and worldwide market players, esteem chain streamlining, exchange guidelines, late turns of events, openings examination, vital market development examination, item dispatches, region commercial center extending, and mechanical advancements.
The focuses that are talked about inside the report are the…
Gemigliptin Market Regional Growth Drivers, Opportunities and Trends 2021-2027| …
Gemigliptin (rINN), sold under the brand name Zemiglo, is an oral anti-hyperglycemic agent (anti-diabetic drug) of the dipeptidyl peptidase-4 inhibitor (DPP-4 inhibitor) class of drugs. Glucose lowering effects of DPP-4 inhibitors are mainly mediated by GLP-1 and gastric inhibitory polypeptide (GIP) incretin hormones which are inactivated by DPP-4.[medical citation needed]
Gemigliptin was initially developed solely by LG Life Sciences. In 2010, Double-Crane Pharmaceutical Co. (DCPC) joined with LGLS to co-develop the…
Dipeptidyl Peptidase 4 (DPP-4) Inhibitors Market Size, Share, Impressive Industr …
The global dipeptidyl peptidase 4 (DPP-4) inhibitors market is anticipated to grow significantly at a CAGR of 3.5% over the forecast period (2020-2026). The global dipeptidyl peptidase 4 (DPP-4) inhibitors market is sectioned on the basis of drug type. The market is sectioned as Sitagliptin, Vildagliptin, Saxagliptin, Linagliptin, Gemigliptin, Anagliptin, Teneligliptin, and Others. Amongst these drug types of the global dipeptidyl peptidase 4 (DPP-4) inhibitors, the Sitagliptin and Saxagliptin are…
Gemigliptin Market global outlook and forecast 2021 -2027|Sanofi,LG Chem
The Global Gemigliptin Market research report is a careful examination of the worldwide industry which has been a region of enthusiasm for a Gemigliptin makers, organizations, authorities, chiefs, and likely speculators, and analysts. The report profoundly lights up noteworthy features in the business, including a contention situation, condition, portions, showcase size, share, gainfulness, development potential, and advancements.
The report likewise spins around the most powerful factors of…
Gemigliptin L-tartrate sesquihydrate Market global outlook and forecast 2021 -20 …
The Global Gemigliptin L-tartrate sesquihydrate Market research report is a careful examination of the worldwide industry which has been a region of enthusiasm for a Gemigliptin L-tartrate sesquihydrate makers, organizations, authorities, chiefs, and likely speculators, and analysts. The report profoundly lights up noteworthy features in the business, including a contention situation, condition, portions, showcase size, share, gainfulness, development potential, and advancements.
The report likewise spins around the…
